Vitiligo futures (investigators)

CLINUVEL is evaluating its drug afamelanotide as an investigational therapy for repigmentation in vitiligo.

We are recruiting investigators and sites for this program.

Register your interest to learn more

Email address*

Confirm Email address*

Title*

First name*

Family name*

Telephone number*

Location*

How many vitiligo patients do you see in a month?*

Do you have narrowband unit?*

Do you see patients with darker skin types (Fitzpatrick skin phototypes III–VI)?*

I confirm that I give CLINUVEL permission to store necessary information and share it with third parties for the purpose of enrolling in a clinical trial. I also consent to being contacted regarding participation in CLINUVEL's vitiligo program. I understand that I can withdraw my permission at any time by emailing clinicaltrials@clinuvel.com.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vitiligo futures

Register your interest to learn more

Vitiligo

About CLINUVEL